Where I see patients (5)
Selected research
-
MRD at the End of Induction and EFS in T-cell Lymphoblastic Lymphoma: Children's Oncology Group Trial AALL1231.
Blood
-
EML4::ALK fusions in complex lymphatic malformations.
Pediatric blood & cancer
-
Current practices in pediatric hospital-acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium.
Research and practice in thrombosis and haemostasis
Clinical trials
A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Seve...
The median time to failure or death will be compared on the two arms using the log-rank test. Failure of IST is defined as the date that a second definitive therapy was recommended (BMT, second course of ATG) and failure of BMT de...
Recruiting
More about this studyTreosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatmen...
The primary endpoint is the incidence of 1-year GVHD free, EFS (GEFS). An event is defined as death due to any cause, graft rejection/failure, or 2nd HCT whichever occurs first. Grade III-IV acute GVHD and chronic GVHD (using NIH ...
Recruiting
More about this studyStudy to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thr...
Durable platelet response is defined as a proportion of participants able to achieve platelet counts at or above 50,000/μL for ≥ two-thirds of at least 8 non-missing weekly scheduled platelet measurements during the last 12 weeks ...
Recruiting
More about this studyApixaban for the Acute Treatment of Venous Thromboembolism in Children
The composite of major and clinically relevant non major bleeding.
Recruiting
More about this studyContact me
Stress-free visits